NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)BREAKTHROUGH T1D, founded in 1970, is a major nonprofit in the Diseases & Disorders sector that reported $301.7M in total revenue in fiscal year 2024. Revenue grew 17% year-over-year, indicating healthy expansion. Expenses of $281.0M left a modest 7% surplus.
BREAKTHROUGH T1D IS THE LEADING GLOBAL T1D ORGANIZATION WORKING TO ACCELERATE LIFE-CHANGING BREAKTHROUGHS TO CURE, PREVENT, AND TREAT T1D AND ITS COMPLICATIONS.
RESEARCH FUNDING -- FOR THE YEAR ENDED JUNE 30, 2025, BREAKTHROUGH T1D (FORMERLY JDRF) DIRECTLY FUNDED RESEARCH GRANTS AND INDUSTRY AGREEMENTS FOR WHICH $121.1 MILLION IN RESEARCH GRANT EXPENSE, NET...
RESEARCH FUNDING -- FOR THE YEAR ENDED JUNE 30, 2025, BREAKTHROUGH T1D (FORMERLY JDRF) DIRECTLY FUNDED RESEARCH GRANTS AND INDUSTRY AGREEMENTS FOR WHICH $121.1 MILLION IN RESEARCH GRANT EXPENSE, NET WAS RECOGNIZED ACCORDING TO GAAP IN ADDITION TO $15.5 MILLION OF PROGRAMMATIC RESEARCH INVESTMENTS THAT ARE RECORDED ON BREAKTHROUGH T1D'S BALANCE SHEET. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO DIRECT RESEARCH FUNDING, SEE SCHEDULE O.
PUBLIC EDUCATION -- BREAKTHROUGH T1D (FORMERLY JDRF) EDUCATES THE COMMUNITY ABOUT TYPE 1 DIABETES (T1D) AND ITS COMPLICATIONS AND PROVIDES SUPPORT SERVICES AND RESOURCES TO DIAGNOSED CHILDREN AND...
PUBLIC EDUCATION -- BREAKTHROUGH T1D (FORMERLY JDRF) EDUCATES THE COMMUNITY ABOUT TYPE 1 DIABETES (T1D) AND ITS COMPLICATIONS AND PROVIDES SUPPORT SERVICES AND RESOURCES TO DIAGNOSED CHILDREN AND ADULTS, THEIR FAMILIES, AND OTHERS. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO PUBLIC EDUCATION AND OUTREACH, SEE SCHEDULE O.
RESEARCH SUPPORT -- BREAKTHROUGH T1D (FORMERLY JDRF) MAINTAINS AN IN-HOUSE TEAM OF SKILLED SCIENTIFIC, MEDICAL, POLICY, AND GOVERNMENT RELATIONS PROFESSIONALS WHO PLAY A CRITICAL ROLE IN LEADING AND...
RESEARCH SUPPORT -- BREAKTHROUGH T1D (FORMERLY JDRF) MAINTAINS AN IN-HOUSE TEAM OF SKILLED SCIENTIFIC, MEDICAL, POLICY, AND GOVERNMENT RELATIONS PROFESSIONALS WHO PLAY A CRITICAL ROLE IN LEADING AND SUPPORTING THE EVALUATION OF RESEARCH FUNDING OPPORTUNITIES BY BREAKTHROUGH T1D AND INFLUENCING RESEARCH DIRECTION AND THE DISBURSEMENT OF RESEARCH FUNDS FROM OTHERS. THESE PROFESSIONALS ALSO WORK WITH REGULATORY AND POLICY OFFICIALS TO ENSURE THAT RESEARCH CAN PROCEED WITHOUT DELAY AND RESULTS ARE UNDERSTOOD BY HEALTHCARE DECISION MAKERS. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO RESEARCH SUPPORT, SEE SCHEDULE O.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $301,723,973 | $258,115,457 | +0.2% |
| Expenses | $281,012,901 | $232,130,154 | +0.2% |
| Net Income | $20,711,072 | $25,985,303 | -0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| LISA WALLACK | CHAIR | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| MATT VAREY | VICE CHAIR | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| MICHAEL ALTER | BOARD MEMBER | 3.00 |
Director
|
$0 | $0 | $0 |
| ELIZABETH CASWELL | CHAIR, TALENT & COMP. COMM. | 5.00 |
Director
|
$0 | $0 | $0 |
| CLAUDIA GRAHAM PHD | BOARD MEMBER | 3.00 |
Director
|
$0 | $0 | $0 |
| MIKE GORDON | BOARD MEMBER (START 7/24) | 3.00 |
Director
|
$0 | $0 | $0 |
| MICHELLE GRIFFIN | BOARD MEMBER | 3.00 |
Director
|
$0 | $0 | $0 |
| KAREN JORDAN | CHAIR, FINANCE & INVESTMENT COMMITTEE | 5.00 |
Director
|
$0 | $0 | $0 |
| JOE LACHER JR | BOARD MEMBER | 3.00 |
Director
|
$0 | $0 | $0 |
| PER LUNDIN | BOARD MEMBER (START 7/24) | 3.00 |
Director
|
$0 | $0 | $0 |
| CARLTON MCMILLAN | BOARD MEMBER | 3.00 |
Director
|
$0 | $0 | $0 |
| JENNIFER SCHNEIDER MD | CHAIR, MISSION IMPACT COMM. | 5.00 |
Director
|
$0 | $0 | $0 |
| CHRISTOPHER TURNER | CHAIR, NOMINATING & GOV. COMM. | 5.00 |
Director
|
$0 | $0 | $0 |
| DRAYTON VIRKLER | BOARD MEMBER | 3.00 |
Director
|
$0 | $0 | $0 |
| KAREY L WITTY | BOARD MEMBER | 3.00 |
Director
|
$0 | $0 | $0 |
| AARON KOWALSKI | CHIEF EXECUTIVE OFFICER | 50.00 |
Officer
|
$978,057 | $70,695 | $1,048,752 |
| JESSE RABEN | CHIEF LEGAL & RISK OFC, SECRETARY | 50.00 |
Officer
|
$319,780 | $63,802 | $383,582 |
| ROBERT KING | CFAO/TREASURER (END 1/25) | 50.00 |
Officer
|
$562,889 | $17,682 | $580,571 |
| MARGARET MORRIS | CFO, TREASURER (START 3/25) | 50.00 |
Officer
|
$248,864 | $30,896 | $279,760 |
| ANNETTE FREYTAG | CHIEF OF STAFF, TREAS (1/25-3/25) | 50.00 |
Officer
|
$79,666 | $9,530 | $89,196 |
| KATHLEEN SEITZ | CHIEF GLOBAL DEVELOPMENT OFFICER | 50.00 |
Key Emp
|
$491,837 | $68,118 | $559,955 |
| SANJOY DUTTA PHD | CHIEF SCIENTIFIC OFFICER | 50.00 |
Key Emp
|
$460,316 | $20,141 | $480,457 |
| STEVEN ST PETER | MANAGING DIR. T1D FUND (END 1/25) | 50.00 |
Key Emp
|
$807,240 | $52,820 | $860,060 |
| AMY MONTALTO | VICE PRESIDENT, VOLUNTEER ENGAGEMENT | 50.00 |
Highest
|
$296,802 | $13,516 | $310,318 |
| HARDIK SANGHVI | VP, ENTERPRISE ARCHITECTURE AND SE | 50.00 |
Highest
|
$296,283 | $51,906 | $348,189 |
| LYNN STARR | CHIEF GLOBAL ADVOCACY OFFICER | 50.00 |
Highest
|
$460,919 | $44,490 | $505,409 |
| PAMELA MORRISROE | CHIEF MARKETING OFFICER | 50.00 |
Highest
|
$520,341 | $44,002 | $564,343 |
| TRACY MIDO | CHIEF HUMAN RESOURCES OFFICER | 50.00 |
Highest
|
$407,842 | $15,242 | $423,084 |
| JAMES MCDONALD | FORMER OFFICER | 0.00 |
|
$148,875 | $7,651 | $156,526 |
| SYDNEY YOVIC | FORMER OFFICER | 0.00 |
|
$296,404 | $36,025 | $332,429 |
| HELEN ELLIAS | FORMER KEY EMPLOYEE | 0.00 |
|
$603,815 | $57,927 | $661,742 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $301,723,973 | $281,012,901 | $534,558,002 | $20,711,072 |
| 2024 | $258,115,457 | $232,130,154 | $488,117,647 | $25,985,303 |
| 2023 | $223,798,085 | $215,759,942 | $446,188,087 | $8,038,143 |
| 2022 | $238,595,505 | $162,889,199 | $389,461,665 | $75,706,306 |
| 2021 | $223,022,643 | $115,470,447 | $361,315,226 | $107,552,196 |
| 2020 | $212,602,450 | $192,605,651 | $268,023,077 | $19,996,799 |
| 2019 | $239,329,465 | $212,570,052 | $244,434,766 | $26,759,413 |
Compare BREAKTHROUGH T1D with other nonprofits in New York and across the country.